Recruiting Ankylosing Spondylitis Studies in Hinsdale
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on in...
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
This study is designed to assess the levels of drug exposure following treatment with tislelizumab administered as a subcutaneous (SC) injection compared to intravenous infusion (IV) as first-line the...
A Study to Evaluate the Efficacy and Safety of Frexalimab, SAR442970, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
This is a parallel, Phase 2a, double-blind, 6-arm study for the treatment of primary focal segmental glomerulosclerosis (FSGS) or primary minimal change disease (MCD). The purpose of this study is to...
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
This is a Phase 1b/2, open-label, parallel-arms pilot study in men and post-menopausal women with hormone receptor positive (HR+), HER2- advanced or metastatic breast cancer with an alteration in the ...
About Ankylosing Spondylitis Clinical Trials in Hinsdale
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 4 ankylosing spondylitis clinical trials recruiting participants in Hinsdale, IL. These studies are seeking a combined 1,887 participants. Research is being sponsored by Novartis Pharmaceuticals, BeiGene, Sanofi and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Hinsdale — FAQ
Are there ankylosing spondylitis clinical trials in Hinsdale?
Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in Hinsdale, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hinsdale?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hinsdale research site will contact you about next steps.
Are clinical trials in Hinsdale free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hinsdale studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 4 active trials in Hinsdale are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated March 2, 2026 from ClinicalTrials.gov